価格表
在庫・価格 : 2024年05月15日 17時42分 現在
商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
---|---|---|---|---|---|---|
Anti-CD31/PECAM-1, Mouse-Mono (TLD-3A12), FITC データシート |
NB100-63703 |
NOVノバス バイオロジカルス Novus biologicals, LLC |
100 μg | ¥139,000 |
無 (未発注) |
追加 |
在庫・価格 : 2024年05月15日 17時42分 現在
使用文献
- No.: 1
-
文献情報:
Willis CL et al. Protein kinase C activation modulates reversible increase in cortical blood-brain barrier permeability and tight junction protein expression during hypoxia and posthypoxic reoxygenation. J. Cereb. Blood Flow Metab. 2010 Nov;30(11):1847-59
Willis CL et al
2010/01/01
-
備考:
Applications: -
参照:
- No.: 2
-
文献情報:
Thebault P et al. The C-type lectin-like receptor CLEC-1, expressed by myeloid cells and endothelial cells, is up-regulated by immunoregulatory mediators and moderates T cell activation. J. Immunol. 2009 Sep;183(5):3099-108
Thebault P et al
2009/01/01
-
備考:
Applications: -
参照:
- No.: 3
-
文献情報:
Lochhead JJ et al. Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J. Cereb. Blood Flow Metab. 2010 Sep;30(9):1625-36
Lochhead JJ et al
2010/01/01
-
備考:
Applications: -
参照:
- No.: 4
-
文献情報:
Kielian T et al. Proinflammatory cytokine, chemokine, and cellular adhesion molecule expression during the acute phase of experimental brain abscess development. Am. J. Pathol. 2000 Aug;157(2):647-58
Kielian T et al
2000/01/01
-
備考:
Applications: -
参照:
- No.: 5
-
文献情報:
Salehi-Had H et al. Utilizing targeted gene therapy with nanoparticles binding alpha v beta 3 for imaging and treating choroidal neovascularization. PLoS ONE 2011;6(4):e18864
Salehi-Had H et al
2011/01/01
-
備考:
Applications: -
参照: